Genmab (GMAB) - Market capitalization

Market cap: NZ$26.20 Billion

As of September 2024 Genmab has a market cap of NZ$26.20 Billion. This makes Genmab the world's 1157th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Genmab from 2010 to 2024

End of year Market Cap

Year	Market cap	Change
2024	NZ$26.20 B	-20.32%
2023	NZ$32.88 B	-25.3%
2022	NZ$44.02 B	15.15%
2021	NZ$38.23 B	3.06%
2020	NZ$37.10 B	73.59%
2019	NZ$21.37 B	43.03%
2018	NZ$14.94 B	5.28%
2017	NZ$14.19 B	-2.01%
2016	NZ$14.48 B	23.77%
2015	NZ$11.70 B	173.95%
2014	NZ$4.27 B	72.76%
2013	NZ$2.47 B	192.24%
2012	NZ$0.84 B	124.86%
2011	NZ$0.37 B	-52.3%
2010	NZ$0.78 B

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Genmab (GMAB)

Market cap: NZ$26.20 Billion